Loading...
9 US Endocrinology Drugs Reports
Country Covered: US
Study Period: 2019 - 2030
Major Players: Abbvie, AstraZeneca, Novartis, Novo Nordisk, Eli Lilly and Company
Country Covered: US
Study Period: 2019 - 2030
Major Players: Abbott Laboratories, Eli Lilly and Company, Teva Pharmaceutical Industries, Endo International, Ferring Pharmaceuticals
Country Covered: US
Study Period: 2019 - 2030
Major Players: Abbvie, Merck, Pfizer, Exelixis, Viatris
Country Covered: US
Study Period: 2019 - 2030
Major Players: Roche, Amgen, Novartis, Viridian Therapeutics Inc., Immunovant Inc.
Country Covered: US
Study Period: 2019 - 2030
Major Players: Endo International, Abbvie, Pfizer, Teva Pharmaceutical Industries, Abbvie
Country Covered: US
Study Period: 2019 - 2030
Major Players: Lannett, Horizon Therapeutics, Takeda Pharmaceuticals, GlaxoSmithKline, Regeneron Pharmaceuticals
Country Covered: US
Study Period: 2019 - 2030
Major Players: Pfizer, Novartis, AstraZeneca, Merck, Sun Pharmaceuticals Industries
Country Covered: US
Study Period: 2019 - 2030
Major Players: Novartis, Ipsen, Pfizer, Recordati S.p.A., Amryt Pharma plc
Country Covered: US
Study Period: 2021 - 2030
Major Players: Sanzyme, Merck, Ferring Pharmaceuticals, Fresenius, Sun Pharmaceuticals Industries